Habit Ledger

Semaglutide, a breakthrough in diabetes and obesity treatment

August 4, 2026 Yustika Amelia

Semaglutide belongs to the class of drugs called glucagon like peptide-1 receptor antagonists (GLP-1RAs). The primary goal of the drug was to improve the health of people with type 2 diabetes. However, it also has the potential to address the complex problem of obesity. Mechanism of Action Semaglutide mimics the...

Medicaid Member Engagement: Empowering Members for Better Health Outcomes

August 2, 2026 Yustika Amelia

Medicaid serves as a critical healthcare safety net for millions of low-income Americans, providing access to essential medical services. However, enrollment alone does not guarantee that members will receive timely and effective care. Medicaid member engagement is essential for improving health outcomes, ensuring preventive care, and promoting overall wellness. By...

Why THCA Is Gaining Attention Fast

August 2, 2026 Yustika Amelia

You might be wondering: what’s the big deal with THCA? In short, THCA is making waves in the health and wellness space for several reasons—especially for customers who are looking for natural alternatives without the strong psychoactive kick of THC. At Utoya, we believe in giving you clarity and quality...